Schedule 13D ownership disclosure

BIOTIME INC

Security class unavailable · CUSIP: 09066L105

Event date: 2014-06-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
118,528,802
Percent of class
14.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-14-033416
Form type
SC 13D/A
Filer
Asterias Biotherapeutics, Inc.
CIK
CIK 1572552
Filed
Aug 19, 2014
Reporting period
Jun 16, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub